Corcept To Pursue High-Dose Corlux For Psychotic Major Depression After Third Phase III Misses Its Mark
This article was originally published in The Pink Sheet Daily
Executive Summary
Funding may be needed, as Corcept’s cash is only expected to last through end of the second quarter.